Clinical Trial Update: Intermittent Letrozole Therapy in Postmenopausal Women With Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluated intermittent Letrozole therapy in postmenopausal women with metastatic breast cancer; the study was terminated with results posted in 20…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Letrozole (letrozole)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Breast Cancer | Phase 2 | Status: TERMINATED | Results posted: 2017-03-22